FRAMINGHAM, MA -- (MARKET WIRE) -- February 21, 2007 -- Symbollon Pharmaceuticals, Inc. (OTCBB: SYMBA) announced the launch of a new web site, www.MyBreastPain.com, to increase awareness of breast pain and tenderness associated with fibrocystic breast disease. The new web site will provide detailed information regarding the condition and allow women suffering from the condition to self assess their symptoms for possible participation in Symbollon’s ongoing Phase III study evaluating IoGen for the treatment of breast pain associated with fibrocystic breast disease.
